Your cart is currently empty!
FDA Approves New Pancreatic Cancer Drug After Trial Nearly Doubled Median Survival

A new treatment has been approved for one of the most difficult cancers to treat, and the clinical trial results behind the decision are already drawing major attention. The FDA has approved Rasonque, also known as daraxonrasib, for certain adults with advanced pancreatic cancer after a study found that patients taking the drug had a…
Scientists Develop New Treatment That Makes Cancer Cells Produce Their Own Anti-Cancer Drugs to Self-Destruct

What if cancer cells could be tricked into pulling the trigger on themselves? For decades, chemotherapy has worked like carpet bombing—effective but imprecise, often harming healthy tissue as much as the tumors it targets. The result? Millions of patients endure the punishing side effects of treatment, from nausea to immune suppression, while scientists continue to…
